|
||||
 |
||||
Ovarian Cancer Treatment — Jeanette Pollock Ovarian cancer, a condition characterized by an overgrowth of malignant cells in one or both of the ovaries, is one of the deadliest and under-recognized cancers affecting women. Every year, there are more than 25,000 women that suffer from this deadly disease. Half of them are most likely to die within a period of five years. Ovarian Cancer Symptoms — Jeanette Pollock Cancer of the ovary, a disease affecting one of both of the ovaries, is one of the most serious and under-recognized ailments affecting women. In United States, it is considered as the fifth among the most fatal gynecologic cancers (affecting the female reproductive organs). It is said that in every 57 women, one may be diagnosed with ovarian cancer and almost half of those women diagnosed with the said cancer may die in a span of five years. Ovarian Cancer: The Silent Killer — Miles Williams Ovarian cancer is the deadliest of gynecological cancers and the fourth-leading cause of cancer death among American women. In 2005, it is estimated that over 22,000 women will be diagnosed with the disease and more than 16,000 will lose their lives to it. Although ovarian cancer is most common in women over the age of 50, it can affect women of any age. Ovarian Cancer Research — Reck Ovarian Cancer Research Ovarian Cancer & Hysterectomies - Becoming Informed About Your Options — Jackie Harvey A hysterectomy is not often a procedure that needs to be performed urgently, except in the case of cancer. Therefore, a woman considering the procedure should take time to investigate all her options, including other possible treatments. There are now new treatments for conditions that previously would have required a hysterectomy. Women advised to have a hysterectomy for a non-cancerous condition before being offered more conservative treatments may find it beneficial to seek a second opinion. Stimulating the Body’s Defenses to Fight Ovarian Cancer — James E. Finch OvaRex® MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex® MAb is given during the ‘watchful waiting’ period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of chemotherapy to treat this illness. Was Your Ovarian Cancer Misdiagnosed? — James Finch Two Percent of All Female Newborns in the United States Are at Risk of Getting Ovarian Cancer Ovarian Cancer, Tea, and An Ounce Of Prevention — Rebecca Prescott Ovarian cancer is an illness that progresses quickly. Discover why one female doctor calls a woman's ovaries her female balls, and her unique view on what they may be saying when they develop cancer. Also, find out what common ingredient reduced a woman's risk of ovarian cancer by 46% Abdominal Chemo Increases Ovarian Cancer Survival Rate — David C Skul A large clinical test shows that giving chemotherapy directly into the stomach, as well as into a vein, can improve survival of women with advanced ovarian cancer by about sixteen months. The results of the study, which pop up in this week's issue of the New England Journal of Medicine, prompted the National Cancer Institute to issue a statement supporting doctors to employ this plan of attack for appropriate patients. | 1 | |
||||
| Copyright © 2006 HYUX.com |